A Randomized, Double-blind, Parallel Group Phase III Multi-center Trial to Compare Twice Daily Topical Application of M518101, Daivonex® and Vehicle in Patients With Plaque Psoriasis III
Phase of Trial: Phase III
Latest Information Update: 26 May 2015
Price : $35 *
At a glance
- Drugs Pefcalcitol (Primary) ; Calcipotriol
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Maruho
- 05 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2014 Planned primary completion date changed from 1 Sep 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 29 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.